TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prospective Randomized Comparison of the Trans-obturator Mid-urethral Sling and the Single-incision Sling in Women With Stress Urinary Incontinence
Brief Summary: Mid-urethral slings (MUS) now represent a gold standard in the treatment of female stress urinary incontinence (SUI). Second generation trans-obturator slings (TOT) have proven to be as effective as retropubic tension-free vaginal tape (TVT) with fewer major complications. A third generation of the MUS inserted through a single vaginal incision (SIS) has become a means to overcome significant post-operative groin pain. Novel types of SIS with a more robust and adjustable anchoring mechanism can assure adequate long-lasting attachment to the obturator membrane (OM). Objective of this study was to compare an inside-out TOT with an innovative fixation SIS in randomized controlled trial on patients undergoing their primary surgery for urodynamic SUI.


Options:
A: Arm Label: SIS single incision sling; Type: EXPERIMENTAL; Interventions: Device: SIS - Innovative fixation single incision sling | Arm Label: TOT trans obturator tape/sling; Type: ACTIVE_COMPARATOR; Interventions: Device: TOT - inside-out trans-obturator tape/sling | Intervention Type: DEVICE; Name: TOT - inside-out trans-obturator tape/sling; Assigned to Arm(s): TOT trans obturator tape/sling | Intervention Type: DEVICE; Name: SIS - Innovative fixation single incision sling; Assigned to Arm(s): SIS single incision sling
B: Arm Label: Single-incision Mini-slings (SIMS- Ajust); Type: EXPERIMENTAL; Interventions: Procedure: sub-urethral tape (TVT-O) | Arm Label: standared med urethral sling (SMUS); Type: OTHER; Interventions: Other: stand standard mid-urethral sling (TVT-O) | Intervention Type: PROCEDURE; Name: sub-urethral tape (TVT-O); Assigned to Arm(s): Single-incision Mini-slings (SIMS- Ajust) | Intervention Type: OTHER; Name: stand standard mid-urethral sling (TVT-O); Assigned to Arm(s): standared med urethral sling (SMUS)
C: Arm Label: TVT Secur surgical device; Type: EXPERIMENTAL; Interventions: Procedure: TVT Secur (Gynecare) | Arm Label: TVT surgical device; Type: ACTIVE_COMPARATOR; Interventions: Procedure: TVT (Gynecare) | Intervention Type: PROCEDURE; Name: TVT Secur (Gynecare); Assigned to Arm(s): TVT Secur surgical device | Intervention Type: PROCEDURE; Name: TVT (Gynecare); Assigned to Arm(s): TVT surgical device
D: Arm Label: TVT; Type: ACTIVE_COMPARATOR; Interventions: Device: Tension Free Vaginal Tape | Arm Label: Miniarc; Type: EXPERIMENTAL; Interventions: Device: Miniarc | Intervention Type: DEVICE; Name: Tension Free Vaginal Tape; Assigned to Arm(s): TVT | Intervention Type: DEVICE; Name: Miniarc; Assigned to Arm(s): Miniarc

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Trial to Determine the Nutritional Requirement for Vitamin D for Prevention of Deficiency During Pregnancy and in the Early Neonatal Period (D-MAT)
Brief Summary: Randomised, placebo-controlled dose-response intervention study with vitamin D3 in pregnant women.


Options:
A: Arm Label: monitored group; Type: EXPERIMENTAL; Interventions: Dietary Supplement: monitored vit D supplementation | Arm Label: standard group; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: standard vit D supplementation | Intervention Type: DIETARY_SUPPLEMENT; Name: monitored vit D supplementation; Assigned to Arm(s): monitored group | Intervention Type: DIETARY_SUPPLEMENT; Name: standard vit D supplementation; Assigned to Arm(s): standard group
B: Intervention Type: OTHER; Name: Blood and breastmilk samples; Assigned to Arm(s): N/A
C: Arm Label: Vitamin D; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Cholecalciferol D3 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo tablet | Intervention Type: DIETARY_SUPPLEMENT; Name: Cholecalciferol D3; Assigned to Arm(s): Vitamin D | Intervention Type: OTHER; Name: Placebo tablet; Assigned to Arm(s): Placebo
D: Arm Label: 10 mcg Vitamin D3; Type: EXPERIMENTAL; Interventions: Dietary Supplement: 10 mcg Vitamin D3 | Arm Label: 20 mcg Vitamin D3; Type: EXPERIMENTAL; Interventions: Dietary Supplement: 20 mcg Vitamin D3 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: 10 mcg Vitamin D3; Assigned to Arm(s): 10 mcg Vitamin D3 | Intervention Type: DIETARY_SUPPLEMENT; Name: 20 mcg Vitamin D3; Assigned to Arm(s): 20 mcg Vitamin D3 | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Trial to Determine the Nutritional Requirement for Vitamin D for Prevention of Deficiency During Pregnancy and in the Early Neonatal Period (D-MAT)
Brief Summary: Randomised, placebo-controlled dose-response intervention study with vitamin D3 in pregnant women.


Options:
A: Arm Label: Vitamin D treatment; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin D 3 cholecalciferol, Dietary Supplement: Vitamin D3 | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Vitamin D3 | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D 3 cholecalciferol; Assigned to Arm(s): Vitamin D treatment | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D3; Assigned to Arm(s): Vitamin D treatment, placebo
B: Arm Label: Group A; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Arm Label: Group B; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin D3 (cholecalciferol), Dietary Supplement: Placebo | Arm Label: Group C; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin D3 (cholecalciferol), Dietary Supplement: Placebo | Arm Label: Group D; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin D3 (cholecalciferol), Dietary Supplement: Placebo | Arm Label: Group E; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin D3 (cholecalciferol) | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D3 (cholecalciferol); Assigned to Arm(s): Group B, Group C, Group D, Group E | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Group A, Group B, Group C, Group D
C: Arm Label: 10 mcg Vitamin D3; Type: EXPERIMENTAL; Interventions: Dietary Supplement: 10 mcg Vitamin D3 | Arm Label: 20 mcg Vitamin D3; Type: EXPERIMENTAL; Interventions: Dietary Supplement: 20 mcg Vitamin D3 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: 10 mcg Vitamin D3; Assigned to Arm(s): 10 mcg Vitamin D3 | Intervention Type: DIETARY_SUPPLEMENT; Name: 20 mcg Vitamin D3; Assigned to Arm(s): 20 mcg Vitamin D3 | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Low dose vitamin D; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Euro D | Arm Label: High dose vitamin D; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Euro D | Intervention Type: DIETARY_SUPPLEMENT; Name: Euro D; Assigned to Arm(s): Low dose vitamin D | Intervention Type: DIETARY_SUPPLEMENT; Name: Euro D; Assigned to Arm(s): High dose vitamin D

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Trial to Determine the Nutritional Requirement for Vitamin D for Prevention of Deficiency During Pregnancy and in the Early Neonatal Period (D-MAT)
Brief Summary: Randomised, placebo-controlled dose-response intervention study with vitamin D3 in pregnant women.


Options:
A: Arm Label: A1 - non-pregnant single-dose; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin D3 | Arm Label: A2 - non-pregnant; weekly dose; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin D3 | Arm Label: B1 - pregnant; single-dose; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin D3 | Arm Label: B2 - pregnant; weekly dose; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin D3 | Arm Label: C1 - active control; pregnant women; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Vitamin D3 | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D3; Assigned to Arm(s): A1 - non-pregnant single-dose, B1 - pregnant; single-dose | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D3; Assigned to Arm(s): A2 - non-pregnant; weekly dose, B2 - pregnant; weekly dose | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D3; Assigned to Arm(s): C1 - active control; pregnant women
B: Arm Label: Vitamin D; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Cholecalciferol D3 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo tablet | Intervention Type: DIETARY_SUPPLEMENT; Name: Cholecalciferol D3; Assigned to Arm(s): Vitamin D | Intervention Type: OTHER; Name: Placebo tablet; Assigned to Arm(s): Placebo
C: Arm Label: Study group; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: D Max drops | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: D Max drops; Assigned to Arm(s): Study group
D: Arm Label: 10 mcg Vitamin D3; Type: EXPERIMENTAL; Interventions: Dietary Supplement: 10 mcg Vitamin D3 | Arm Label: 20 mcg Vitamin D3; Type: EXPERIMENTAL; Interventions: Dietary Supplement: 20 mcg Vitamin D3 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: 10 mcg Vitamin D3; Assigned to Arm(s): 10 mcg Vitamin D3 | Intervention Type: DIETARY_SUPPLEMENT; Name: 20 mcg Vitamin D3; Assigned to Arm(s): 20 mcg Vitamin D3 | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Very Intensive Variable Repetitive AmbulatioN Training
Brief Summary: The overall objective of this subproject is to evaluate the individual and paired contributions of intensity and variability of stepping training on lower extremity (LE) function, health and community participation in patients with chronic hemiparesis post-stroke.


Options:
A: Arm Label: Intensive Walking; Type: EXPERIMENTAL; Interventions: Behavioral: Intensive Walking | Arm Label: Conventional Physical Therapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Conventional Physical Therapy | Intervention Type: BEHAVIORAL; Name: Intensive Walking; Assigned to Arm(s): Intensive Walking | Intervention Type: BEHAVIORAL; Name: Conventional Physical Therapy; Assigned to Arm(s): Conventional Physical Therapy
B: Intervention Type: OTHER; Name: Robot-assisted therapy; Assigned to Arm(s): N/A
C: Arm Label: Variable high-intensity Training; Type: EXPERIMENTAL; Interventions: Behavioral: exercise | Arm Label: Variable low-intensity training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: exercise | Arm Label: Constant High Intensity Training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: exercise | Intervention Type: BEHAVIORAL; Name: exercise; Assigned to Arm(s): Constant High Intensity Training, Variable high-intensity Training, Variable low-intensity training
D: Arm Label: enhanced upper-extremity program, EUEP; Type: EXPERIMENTAL; Interventions: Other: UFT | Arm Label: enhanced lower-extremity program,ELLP); Type: EXPERIMENTAL; Interventions: Other: LFT | Intervention Type: OTHER; Name: UFT; Assigned to Arm(s): enhanced upper-extremity program, EUEP | Intervention Type: OTHER; Name: LFT; Assigned to Arm(s): enhanced lower-extremity program,ELLP)

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Very Intensive Variable Repetitive AmbulatioN Training
Brief Summary: The overall objective of this subproject is to evaluate the individual and paired contributions of intensity and variability of stepping training on lower extremity (LE) function, health and community participation in patients with chronic hemiparesis post-stroke.


Options:
A: Arm Label: Trunk training; Type: EXPERIMENTAL; Interventions: Other: Trunk training | Arm Label: Cognitive exercises; Type: SHAM_COMPARATOR; Interventions: Other: Cognitive exercises | Intervention Type: OTHER; Name: Trunk training; Assigned to Arm(s): Trunk training | Intervention Type: OTHER; Name: Cognitive exercises; Assigned to Arm(s): Cognitive exercises
B: Arm Label: Variable high-intensity Training; Type: EXPERIMENTAL; Interventions: Behavioral: exercise | Arm Label: Variable low-intensity training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: exercise | Arm Label: Constant High Intensity Training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: exercise | Intervention Type: BEHAVIORAL; Name: exercise; Assigned to Arm(s): Constant High Intensity Training, Variable high-intensity Training, Variable low-intensity training
C: Arm Label: Vojta arm; Type: EXPERIMENTAL; Interventions: Other: Vojta therapy | Arm Label: conventional physiotherapy arm; Type: ACTIVE_COMPARATOR; Interventions: Other: conventional physiotherapy | Intervention Type: OTHER; Name: Vojta therapy; Assigned to Arm(s): Vojta arm | Intervention Type: OTHER; Name: conventional physiotherapy; Assigned to Arm(s): conventional physiotherapy arm
D: Arm Label: Guided Self-rehabilitation Contract; Type: ACTIVE_COMPARATOR; Interventions: Other: Guided Self-rehabilitation Contract | Arm Label: Conventional rehabilitation; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Guided Self-rehabilitation Contract; Assigned to Arm(s): Guided Self-rehabilitation Contract

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The POP-study: Effect of Probiotics on Weight, Microbiota and Glucose Tolerance in Obese Pregnant Women and Their Newborn - a Randomized, Double-blind Placebo Controlled Trial With Vivomixx®
Brief Summary: The purpose of the study is to investigate if the probiotics Vivomixx® can affect gestational weight gain, microbiota and pregnancy complications in pregnant obese women and birth weight body composition of their infants.


Options:
A: Arm Label: Probiotic; Type: EXPERIMENTAL; Interventions: Biological: Lactobacillus salivarius PS2 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Excipient (milk powder) | Intervention Type: BIOLOGICAL; Name: Lactobacillus salivarius PS2; Assigned to Arm(s): Probiotic | Intervention Type: BIOLOGICAL; Name: Excipient (milk powder); Assigned to Arm(s): Placebo
B: Arm Label: Vivomixx®; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vivomixx® | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Vivomixx®; Assigned to Arm(s): Vivomixx® | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Probiotics; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Probiotics | Arm Label: Probiotics + Dietary counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary counselling and probiotics | Arm Label: Dietary counseling + placebo; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary counselling and placebo | Arm Label: Prebiotics; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Prebiotics | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo capsules | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Dietary counselling and placebo; Assigned to Arm(s): Dietary counseling + placebo | Intervention Type: BEHAVIORAL; Name: Dietary counselling and probiotics; Assigned to Arm(s): Probiotics + Dietary counseling | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo capsules; Assigned to Arm(s): Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Probiotics; Assigned to Arm(s): Probiotics | Intervention Type: DIETARY_SUPPLEMENT; Name: Prebiotics; Assigned to Arm(s): Prebiotics
D: Arm Label: Probiotic; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Lactobacillus rhamnosus GR-1 | Arm Label: Milk; Type: OTHER; Interventions: Dietary Supplement: Pasteurized Whole Milk | Intervention Type: DIETARY_SUPPLEMENT; Name: Pasteurized Whole Milk; Assigned to Arm(s): Milk | Intervention Type: DIETARY_SUPPLEMENT; Name: Lactobacillus rhamnosus GR-1; Assigned to Arm(s): Probiotic

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The POP-study: Effect of Probiotics on Weight, Microbiota and Glucose Tolerance in Obese Pregnant Women and Their Newborn - a Randomized, Double-blind Placebo Controlled Trial With Vivomixx®
Brief Summary: The purpose of the study is to investigate if the probiotics Vivomixx® can affect gestational weight gain, microbiota and pregnancy complications in pregnant obese women and birth weight body composition of their infants.


Options:
A: Arm Label: Probiotics; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Probiotics | Arm Label: Probiotics + Dietary counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary counselling and probiotics | Arm Label: Dietary counseling + placebo; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary counselling and placebo | Arm Label: Prebiotics; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Prebiotics | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo capsules | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Dietary counselling and placebo; Assigned to Arm(s): Dietary counseling + placebo | Intervention Type: BEHAVIORAL; Name: Dietary counselling and probiotics; Assigned to Arm(s): Probiotics + Dietary counseling | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo capsules; Assigned to Arm(s): Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Probiotics; Assigned to Arm(s): Probiotics | Intervention Type: DIETARY_SUPPLEMENT; Name: Prebiotics; Assigned to Arm(s): Prebiotics
B: Arm Label: probiotic femina II; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Femina II | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Femina II; Assigned to Arm(s): probiotic femina II | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Vivomixx®; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vivomixx® | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Vivomixx®; Assigned to Arm(s): Vivomixx® | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Probiotic; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Comparison of probiotics, fish oil and their combination to placebo | Arm Label: Fish oil; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Comparison of probiotics, fish oil and their combination to placebo | Arm Label: Probiotics and Fish oil; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Comparison of probiotics, fish oil and their combination to placebo | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Comparison of probiotics, fish oil and their combination to placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Comparison of probiotics, fish oil and their combination to placebo; Assigned to Arm(s): Fish oil, Placebo, Probiotic, Probiotics and Fish oil

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Vitamin D3 for Autism Spectrum Disorder: a Randomized, Double-blind, Placebo-controlled Trial.
Brief Summary: To build on a recent case study and open label trial, the investigators want to find out if vitamin D supplementation can influence behavioural and core symptoms of autism.


Options:
A: Arm Label: High-dose vitamin D; Type: EXPERIMENTAL; Interventions: Drug: High-dose vitamin D 3 | Arm Label: Conventional-dose vitamin D; Type: ACTIVE_COMPARATOR; Interventions: Drug: Conventional-Dose Vitamin D 3 | Intervention Type: DRUG; Name: High-dose vitamin D 3; Assigned to Arm(s): High-dose vitamin D | Intervention Type: DRUG; Name: Conventional-Dose Vitamin D 3; Assigned to Arm(s): Conventional-dose vitamin D
B: Arm Label: Vitamin D3; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin D3 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D3; Assigned to Arm(s): Vitamin D3 | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Enteral Loading Arm; Type: EXPERIMENTAL; Interventions: Drug: Vitamin D3 | Arm Label: Placebo Arm; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Vitamin D3; Assigned to Arm(s): Enteral Loading Arm | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo Arm
D: Arm Label: 400 IU/day vitamin D; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: cholecalciferal | Arm Label: 800 IU/day vitamin D3; Type: EXPERIMENTAL; Interventions: Dietary Supplement: cholecalciferol | Intervention Type: DIETARY_SUPPLEMENT; Name: cholecalciferal; Assigned to Arm(s): 400 IU/day vitamin D | Intervention Type: DIETARY_SUPPLEMENT; Name: cholecalciferol; Assigned to Arm(s): 800 IU/day vitamin D3

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: WEB-Based Physiotherapy for People With Multiple Sclerosis
Brief Summary: The study will be a pragmatic, single blind, randomised, controlled feasibility study, comparing 6 months of web-based physiotherapy plus usual care with usual care alone in pwMS. The study will recruit 90 pwMS from three UK Centres (30 from each centre); NHS Ayrshire and Arran, NHS Lothian, and Plymouth Hospitals NHS Trust.

The aim of this study is to assess the feasibility of a randomised controlled trial examining the effectiveness of a six-month web-based physiotherapy programme and usual care compared to usual care alone, in people moderately affected by MS and to gather essential information for the planning of a definitive trial, which would evaluate both clinical and cost effectiveness of the intervention.


Options:
A: Arm Label: Telerehabilitation programme; Type: EXPERIMENTAL; Interventions: Device: Telerehabilitation programme | Arm Label: Control group traditional rehabilitation; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Telerehabilitation programme; Assigned to Arm(s): Telerehabilitation programme
B: Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Telehealth Pulmonary Rehabilitation | Intervention Type: OTHER; Name: Telehealth Pulmonary Rehabilitation; Assigned to Arm(s): Intervention
C: Arm Label: BESMILE-HF group; Type: EXPERIMENTAL; Interventions: Behavioral: BESMILE-HF program, Drug: Usual medications | Arm Label: Control; Type: OTHER; Interventions: Drug: Usual medications | Intervention Type: BEHAVIORAL; Name: BESMILE-HF program; Assigned to Arm(s): BESMILE-HF group | Intervention Type: DRUG; Name: Usual medications; Assigned to Arm(s): BESMILE-HF group, Control
D: Arm Label: Web-based physio; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise | Arm Label: Print-out exercise programme; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Exercise | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Print-out exercise programme, Web-based physio

Answer: D